(Q33396340)

26 July 2017

1 reference

title

Drug metabolism by leukocytes and its role in drug-induced lupus and other idiosyncratic drug reactions (English)

1 reference

26 July 2017

Uetrecht J

1

1 reference

PubMed ID

2178625

26 July 2017

language of work or name

English

0 references

publication date

1 January 1990

1 reference

Critical Reviews in Toxicology

26 July 2017

1 reference

26 July 2017

20

1 reference

26 July 2017

213-235

1 reference

26 July 2017

4

1 reference

Statewide Study of Chloramphenicol Therapy and Fatal Aplastic Anemia

26 July 2017

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Reye's syndrome and aspirin. Evidence for a dose-response effect

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Aspirin as a risk factor in Reye's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

The immunologic and metabolic basis of drug hypersensitivities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

The basis for the immunoregulatory role of macrophages and other accessory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Evidence for expression in human liver of halothane-induced neoantigens recognized by antibodies in sera from patients with halothane hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Metabolites of procainamide and practolol inhibit complement components C3 and C4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Depression of immunological function in patients treated with phenytoin sodium (sodium diphenylhydantoin).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

IgA deficiency, epilepsy, and phenytoin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Assessment of polymorphonucleate leucocyte functions in adult epileptic patients undergoing long-term phenytoin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Acetylator phenotype and lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Clinicopathological study of a patient with procainamide-induced systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Mechanism of drug-induced lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Disease activity in systemic lupus erythematosus related to a range of antibodies binding DNA and synthetic polynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Antibodies to Histones in Drug-Induced and Idiopathic Lupus Erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Origins of anti-DNA autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Antinuclear antibody induced by procainamide. A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Antibodies to Nuclear Antigens in Patients Treated with Procainamide or Acetylprocainamide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Remission of Procainamide-Induced Lupus Erythematosus with N-Acetylprocainamide Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Acetylprocainamide Therapy in Patients with Previous Procainamide-Induced Lupus Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Metabolism of procainamide to a hydroxylamine by human neutrophils and mononuclear leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Comparative reactivities of various biological compounds with myeloperoxidase-hydrogen peroxide-chloride, and similarity of the oxidant to hypochlorite

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Peroxidase-mediated irreversible binding of arylamine carcinogens to DNA in intact polymorphonuclear leukocytes activated by a tumor promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Facts on the fragmentation of antigens in presenting cells, on the association of antigen fragments with MHC molecules in cell-free systems, and speculation on the cell biology of antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Autoantibodies: terms and concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Myeloperoxidase: a myeloid cell nuclear antigen with DNA-binding properties

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Systemic lupus erythematosus syndrome induced by practolol.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Practolol therapy associated with a systemic lupus erythematosus-like syndrome and an inhibitor to factor XIII

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Development of antinuclear antibodies during acebutolol therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Antinuclear antibodies in patients on acebutolol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Possible role of antibody specific for a practolol metabolite in the pathogenesis of oculomucocutaneous syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Immunological aspects of practolol toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Hydralazine-induced lupus: is there a toxic metabolic pathway?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Granulocytopenia, lupus-like syndrome, and other complications of propylthiouracil therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

An anti-neutrophil antibody associated with a propylthiouracil-induced lupus-like syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Lupus-like syndrome--a rare complication in thionamide treatment for Graves' disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Dose-dependent induction of anti-native DNA antibodies in cats by propylthiouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Systemic lupus erythematosus during penicillamine therapy for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Studies on 5,5-diphenylhydantoin irreversible binding to rat liver microsomal proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Occurrence of systemic lupus erythematosus in association with ethosuccimide therapy. Case report

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Lupus-scleroderma syndrome induced by ethosuximide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

N-chlorination of phenytoin by myeloperoxidase to a reactive metabolite

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

"Collagen disease" due to carbamazepine (Tegretol).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Drug-induced bronchopulmonary pleural disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Glandular fever-like syndrome, pulmonary eosinophilia and asthma associated with carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Carbamazepine and hematological monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Drug-Induced Agranulocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Severe neutropenia associated with sustained-release procainamide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Severe neutropenia associated with procainamide: comparison of sustained release and conventional preparations.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Drug-induced aplastic anaemia and agranulocytosis. Incidence and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Severe transient pancytopenia associated with procainamide ingestion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Agranulocytosis following procainamide administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Drug-induced immunological neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Procainamide-associated pancytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Positive Direct Antiglobulin Tests and Immune Hemolytic Anemia in Patients Receiving Procainamide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Pseudoleukemia during recovery from dapsone-induced agranulocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Agranulocytosis caused by dapsone therapy for granuloma annulare

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Multiple haematologic abnormalities associated with sulfasalazine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Formation and disposition of nitrosochloramphenicol in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Bone marrow toxicity in vitro of chloramphenicol and its metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Aerobic nitroreduction of dehydrochloramphenicol by bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Propylthiouracil-induced agranulocytosis: an unusual presentation and a possible mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Transient Methimazole-induced Bone Marrow Aplasia: in vitro Evidence for a Humoral Mechanism of Bone Marrow Suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Leucopenia in association with mianserin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Clozapine and agranulocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Agranulocytosis during treatment with chlozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

A review of toxic epidermal necrolysis in Britain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

In vitro evaluation of a toxic metabolite of sulfadiazine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Sulfonamide hepatic injury. Review of the literature and report of a case due to sulfamethoxazole

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Fatal multisystemic toxicity associated with prophylaxis with pyrimethamine and sulfadoxine (Fansidar).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Serious complications of sulfasalazine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Sulphasalazine induced lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Fibrosing alveolitis and treatment with sulphasalazine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Drug-induced liver injury. In vitro demonstration of hypersensitivity to both phenytoin and phenobarbital

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Cholestatic liver dysfunction after long-term phenytoin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Fatal Reaction to Dapsone During Treatment of Leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Procainamide-induced hemolytic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Granulomatous hepatitis: a hypersensitivity response to procainamide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Apparent vasculitis associated with propylthiouracil use

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Propylthiouracil-induced cutaneous vasculitis. Case presentation and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Cutaneous vasculitis associated with propylthiouracil therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Drug-specific antibodies in patients receiving captopril

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Association of trimethadione therapy and myasthenia gravis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Aminoglutethimide: a "side-effect" turned to therapeutic advantage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Carcinogenicity of dapsone of mice and rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Sulfonamides and sulfones in dermatologic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Double-blind trial of dapsone against placebo in the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

The inhibition of polymorphonuclear leukocyte cytotoxicity by dapsone. A possible mechanism in the treatment of dermatitis herpetiformis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Current aspects of modes of action of dapsone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Cytochemical expression of epidermal peroxidase and cytochrome oxidase activities in pathological skin conditions of man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: Comparison with procainamide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

The Fetal Trimethadione Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Idiosyncratic reactions to phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Fatal agranulocytosis in a chronic schizophrenic patient treated with carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Aminoglutethimide-induced leukopenia: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

Permanent intrinsic B cell immunodeficiency caused by phenytoin hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

In VitroImmunoreactivity to Propylthiouracil, Methimazole, and Carbimazole in Patients with Graves’ Disease: A Possible Cause of Antithyroid Drug-Induced Agranulocytosis*

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449009089863

10.3109/10408449009089863

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference

PubMed ID

2178625